Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, January 20, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Salveen Richter Maintained (TSVT) at Strong Buy with Increased Target to $28 on, Jan 20th, 2023
Salveen Richter of Goldman Sachs, Maintained "2seventy bio, Inc." (TSVT) at Strong Buy with Increased Target from $25 to $28 on, Jan 20th, 2023.
Salveen has made no other calls on TSVT in the last 4 months.
There are 3 other peers that have a rating on TSVT. Out of the 3 peers that are also analyzing TSVT, 0 agree with Salveen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Salveen
- Daina Graybosch of "SVB Leerink" Maintained at Buy with Decreased Target to $34 on, Tuesday, January 10th, 2023
- Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $29 on, Tuesday, November 8th, 2022
- Kelsey Goodwin of "Guggenheim" Initiated at Strong Buy and Held Target at $30 on, Monday, October 31st, 2022
